Skip to main content

Articles

Page 245 of 251

  1. The purpose of this study was to test the hypothesis that mast cells that are present in fibrotic regions of cancer can suppress the growth of tumor cells through an indirect mechanism involving peri-tumoral f...

    Authors: Michael Samoszuk, Emi Kanakubo and John K Chan

    Citation: BMC Cancer 2005 5:121

    Content type: Research article

    Published on:

  2. PKH67 labelling was compared for classical proliferation assessment (using S phase evaluation) to analyse the cell proliferation of 29 AML patients treated or not with various drugs. Among these drugs, the eff...

    Authors: Jean Boutonnat, Anne-Marie Faussat, Jean-Pierre Marie, Jérôme Bignon, Johanna Wdzieczak-Bakala, Magali Barbier, Josiane Thierry, Xavier Ronot and Pierre-Emmanuel Colle

    Citation: BMC Cancer 2005 5:120

    Content type: Technical advance

    Published on:

  3. The EphB4 receptor tyrosine kinase has been reported as increased in tumours originating from several different tissues and its expression in a prostate cancer xenograft model has been reported.

    Authors: Yen-Ching Lee, Janeanne R Perren, Evelyn L Douglas, Michael P Raynor, Maria A Bartley, Peter G Bardy and Sally-Anne Stephenson

    Citation: BMC Cancer 2005 5:119

    Content type: Research article

    Published on:

  4. Most cervical cancer patients with pelvic recurrent or persistent disease are not candidates for exenteration, therefore, they only receive palliative chemotherapy. Here we report the results of a novel treatm...

    Authors: Carlos Lopez-Graniel, Rigoberto Dolores, Lucely Cetina, Aaron Gonzalez, David Cantu, Jose Chanona, Jesus Uribe, Myrna Candelaria, Rocio Brom, Jaime de la Garza and Alfonso Duenas-Gonzalez

    Citation: BMC Cancer 2005 5:118

    Content type: Research article

    Published on:

  5. The oral cavity is a rare but occasional target for metastases, which may masquerade as various benign and inflammatory lesions, and sometimes also be asymptomatic. Oral metastatic lesions have been described ...

    Authors: Piergiuseppe Colombo, Luca Tondulli, Giovanna Masci, Andrea Muzza, Lorenza Rimassa, Duccio Petrella and Armando Santoro

    Citation: BMC Cancer 2005 5:117

    Content type: Case report

    Published on:

  6. New chemotherapy regimens for patients with colorectal cancer have improved survival, but at the cost of clinical toxicity. Oxaliplatin, an agent used in first-line therapy for metastatic colorectal cancer, ca...

    Authors: Gregory D Leonard, Maurice A Wright, Mary G Quinn, Suzanne Fioravanti, Nancy Harold, Barbara Schuler, Rebecca R Thomas and Jean L Grem

    Citation: BMC Cancer 2005 5:116

    Content type: Research article

    Published on:

  7. Bleomycin is poorly permeant but potent cytotoxic and radiosensitizing drug. The aim of the study was to evaluate whether a physical drug delivery system – electroporation can increase radiosensitising effect ...

    Authors: Simona Kranjc, Maja Cemazar, Alenka Grosel, Marjeta Sentjurc and Gregor Sersa

    Citation: BMC Cancer 2005 5:115

    Content type: Research article

    Published on:

  8. P-glycoprotein is responsible for the ATP-dependent export of certain structurally unrelated compounds including many chemotherapeutic drugs. Amplification of P-glycoprotein activity can result in multi-drug r...

    Authors: Mirela R Fekete, William H McBride and Frank Pajonk

    Citation: BMC Cancer 2005 5:114

    Content type: Research article

    Published on:

  9. The tissue-specific translation elongation factor eEF1A2 was recently shown to be a potential oncogene that is overexpressed in ovarian cancer. Although there is no direct evidence for an involvement of eEF1A2...

    Authors: Victoria AL Tomlinson, Helen J Newbery, Naomi R Wray, Juliette Jackson, Alexey Larionov, William R Miller, J Michael Dixon and Catherine M Abbott

    Citation: BMC Cancer 2005 5:113

    Content type: Research article

    Published on:

  10. Previous reports show a high proportion of young CRC patients in Iran. In this study we aim to look for the clustering of colorectal cancer in families of a series of CRC patients from Iran.

    Authors: Mahboobeh Mahdavinia, Faraz Bishehsari, Reza Ansari, Nasim Norouzbeigi, Ahmad Khaleghinejad, Mahshid Hormazdi, Naser Rakhshani and Reza Malekzadeh

    Citation: BMC Cancer 2005 5:112

    Content type: Research article

    Published on:

  11. The aim of the study was to investigate whether p503S, p504S and p510S gene expression in peripheral-blood be useful as a diagnostic or prognostic marker of prostatic cancer.

    Authors: Maria Rosaria Cardillo, Vincenzo Gentile, Mauro Ciccariello, Laura Giacomelli, Silvio Messinetti and Franco Di Silverio

    Citation: BMC Cancer 2005 5:111

    Content type: Research article

    Published on:

  12. Cancer serum protein profiling by mass spectrometry has uncovered mass profiles that are potentially diagnostic for several common types of cancer. However, direct mass spectrometric profiling has a limited dy...

    Authors: Wei-Min Gao, Rork Kuick, Randal P Orchekowski, David E Misek, Ji Qiu, Alissa K Greenberg, William N Rom, Dean E Brenner, Gilbert S Omenn, Brian B Haab and Samir M Hanash

    Citation: BMC Cancer 2005 5:110

    Content type: Research article

    Published on:

  13. Post-transplant lymphoproliferative disorder (PTLD) is a complication of solid organ and allogeneic hematopoietic stem cell transplantation (HSCT); following autologous HSCT only rare cases of PTLD have been r...

    Authors: Alberto Zambelli, Daniele Lilleri, Fausto Baldanti, Mario Scelsi, Laura Villani and Gian Antonio Da Prada

    Citation: BMC Cancer 2005 5:109

    Content type: Case report

    Published on:

  14. The Cooperative Prostate Cancer Tissue Resource (CPCTR) is a consortium of four geographically dispersed institutions that are funded by the U.S. National Cancer Institute (NCI) to provide clinically annotated...

    Authors: Ashokkumar A Patel, André Kajdacsy-Balla, Jules J Berman, Maarten Bosland, Milton W Datta, Rajiv Dhir, John Gilbertson, Jonathan Melamed, Jan Orenstein, Kuei-Fang Tai and Michael J Becich

    Citation: BMC Cancer 2005 5:108

    Content type: Research article

    Published on:

  15. Chronic lymphocytic leukemia (CLL) is a monoclonal disorder, characterized by a progressive proliferation of functionally incompetent B lymphocytes. There is increased evidence of association between CLL and s...

    Authors: KI Papageorgiou and MG Kaniorou-Larai

    Citation: BMC Cancer 2005 5:106

    Content type: Case report

    Published on:

  16. A common sequence polymorphism at codon 72 of the p53 gene encoding either arginine or proline was recently shown to be functionally relevant for apoptosis induction in vitro. In B-type chronic lymphocytic leu...

    Authors: Isrid Sturm, Andrew G Bosanquet, Michael Hummel, Bernd Dörken and Peter T Daniel

    Citation: BMC Cancer 2005 5:105

    Content type: Research article

    Published on:

  17. Previous data from our laboratory has indicated that there is a functional link between the β-adrenergic receptor signaling pathway and the G-protein inwardly rectifying potassium channel (GIRK1) in human brea...

    Authors: Howard K Plummer III, Madhu S Dhar, Maria Cekanova and Hildegard M Schuller

    Citation: BMC Cancer 2005 5:104

    Content type: Research article

    Published on:

  18. Despite exciting new targeted therapeutics against non-Hodgkin's lymphoma (NHL), chemotherapy remains a cornerstone of therapy. While purine nucleoside analogs have significant activity in low grade NHL, the p...

    Authors: Mitchell R Smith, Indira Joshi, Fang Jin and Coleman Obasaju

    Citation: BMC Cancer 2005 5:103

    Content type: Research article

    Published on:

  19. The mechanisms of chemoresistance in ovarian cancer patients remain largely to be elucidated. Paclitaxel/cisplatin combination is the standard chemotherapeutic treatment for this disease, although some patient...

    Authors: Bárbara Mesquita, Isabel Veiga, Deolinda Pereira, Ana Tavares, Isabel M Pinto, Carla Pinto, Manuel R Teixeira and Sérgio Castedo

    Citation: BMC Cancer 2005 5:101

    Content type: Research article

    Published on:

  20. The purpose of our study was to investigate the immunohistochemical expression of TGF-β1 and p27 in pancreatic adenocarcinomas and to compare the findings with the clinicopathological features and survival. We...

    Authors: Nil Culhaci, Ozgul Sagol, Sedat Karademir, Huseyin Astarcioglu, Ibrahim Astarcioglu, Mujde Soyturk, Ilhan Oztop and Funda Obuz

    Citation: BMC Cancer 2005 5:98

    Content type: Research article

    Published on:

  21. Inhibition of the COP9 signalosome (CSN) associated kinases CK2 and PKD by curcumin causes stabilization of the tumor suppressor p53. It has been shown that curcumin induces tumor cell death and apoptosis. Cur...

    Authors: Melanie Füllbeck, Xiaohua Huang, Renate Dumdey, Cornelius Frommel, Wolfgang Dubiel and Robert Preissner

    Citation: BMC Cancer 2005 5:97

    Content type: Research article

    Published on:

  22. Gene expression data is abundantly available from the Gene Expression Omnibus (GEO) and various websites. Pathway specific analyses of gene-gene correlations across these datasets remain relatively unexplored,...

    Authors: Tomas Radivoyevitch

    Citation: BMC Cancer 2005 5:95

    Content type: Research article

    Published on:

  23. Cancer patients may harbor micrometastases that remain dormant, clinically undetectable during a variable period of time. A traumatic event or surgery may trigger the balance towards tumor growth as a result o...

    Authors: Nagi S El Saghir, Ihab I Elhajj, Fady B Geara and Mukbil H Hourani

    Citation: BMC Cancer 2005 5:94

    Content type: Case report

    Published on:

  24. Breast cancer is one of the most frequent causes of death in Mexican women over 35 years of age. At molecular level, changes in many genetic networks have been reported as associated with this neoplasia. To an...

    Authors: Normand García, Fabio Salamanca, Horacio Astudillo-de la Vega, Everardo Curiel-Quesada, Isabel Alvarado, Rosenda Peñaloza and Diego Arenas

    Citation: BMC Cancer 2005 5:93

    Content type: Research article

    Published on:

  25. Adenomyoepithelial tumours and myoepithelial carcinomas of the breast are primarily defined by the presence of neoplastic cells with a myoepithelial immunophenotype. Current classification schemes are based on...

    Authors: Daniela Hungermann, Horst Buerger, Christian Oehlschlegel, Hermann Herbst and Werner Boecker

    Citation: BMC Cancer 2005 5:92

    Content type: Research article

    Published on:

  26. The RTOG 94-13 trial has provided evidence that patients with high risk prostate cancer benefit from an additional radiotherapy to the pelvic nodes combined with concomitant hormonal ablation. Since lymphatic ...

    Authors: Ute Ganswindt, Frank Paulsen, Stefan Corvin, Kai Eichhorn, Stefan Glocker, Ilse Hundt, Mattias Birkner, Markus Alber, Aristotelis Anastasiadis, Arnulf Stenzl, Roland Bares, Wilfried Budach, Michael Bamberg and Claus Belka

    Citation: BMC Cancer 2005 5:91

    Content type: Research article

    Published on:

  27. Esophagus squamous cell cancer (ESCC) is the most common cancer in women with 20.2% and second in men with 10.7% relative frequency among all cancer cases diagnosed in Van Region in the east of Turkey. Ninety ...

    Authors: Mahmut Ilhan, Tugrul Erbaydar, Necmettin Akdeniz and Sevket Arslan

    Citation: BMC Cancer 2005 5:90

    Content type: Research article

    Published on:

  28. Bisphosphonate therapy has been readily accepted as standard of care for individuals with bone metastases from breast cancer. In this study we determined whether the proportion of patients experiencing a skele...

    Authors: Winston Liauw, Eva Segelov, Anna Lih, Ms Ruth Dunleavy, Matthew Links and Robyn Ward

    Citation: BMC Cancer 2005 5:89

    Content type: Research article

    Published on:

  29. Published data suggests that docetaxel combined with 5-fluorouracil (5-FU) may have synergistic activity in treating advanced gastric cancer. We performed a phase I study of docetaxel and 5-FU to determine the...

    Authors: Se Hoon Park, Soo-Mee Bang, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee, Woon KI Lee and Min Chung

    Citation: BMC Cancer 2005 5:87

    Content type: Research article

    Published on:

  30. Affymetrix GeneChip Array and Massively Parallel Signature Sequencing (MPSS) are two high throughput methodologies used to profile transcriptomes. Each method has certain strengths and weaknesses; however, no ...

    Authors: Asa J Oudes, Jared C Roach, Laura S Walashek, Lillian J Eichner, Lawrence D True, Robert L Vessella and Alvin Y Liu

    Citation: BMC Cancer 2005 5:86

    Content type: Research article

    Published on:

  31. Neurofibromatosis type 1 is an autosomal dominant neurocutaneous disorder with characteristic features of skin and central nervous system involvement. Gastrointestinal involvement is rare, but the risk of mali...

    Authors: Wan-Sik Lee, Yang-Seok Koh, Jung-Chul Kim, Chang-Hwan Park, Young-Eun Joo, Hyun-Soo Kim, Chol-Kyoon Cho, Sung-Kyu Choi, Jong-Sun Rew and Sei-Jong Kim

    Citation: BMC Cancer 2005 5:85

    Content type: Case report

    Published on:

  32. Hypoxia-inducible factor 1 (HIF-1) is a transcription factor, which plays a central role in biologic processes under hypoxic conditions, especially concerning tumour angiogenesis. HIF-1α is the relevant, oxyge...

    Authors: Thomas Fillies, Richard Werkmeister, Paul J van Diest, Burkhard Brandt, Ulrich Joos and Horst Buerger

    Citation: BMC Cancer 2005 5:84

    Content type: Research article

    Published on:

  33. Currently, no satisfactory biomarkers are available to screen for lung cancer. Surface-Enhanced Laser Desorption/ionization Time-of- Flight Mass Spectrometry ProteinChip system (SELDI-TOF-MS) is one of the cur...

    Authors: Shuan-ying Yang, Xue-yuan Xiao, Wang-gang Zhang, Li-juan Zhang, Wei Zhang, Bin Zhou, Guoan Chen and Da-cheng He

    Citation: BMC Cancer 2005 5:83

    Content type: Research article

    Published on:

  34. Data concerning incidence and prevalence of cancer in the different regions of Russia have traditionally not been provided on a basis that facilitated comparison with data from countries in western parts of Eu...

    Authors: Arild Vaktskjold, Jelena A Lebedintseva, Dmitrij S Korotov, Anatolij V Tkatsjov, Tatjana S Podjakova and Eiliv Lund

    Citation: BMC Cancer 2005 5:82

    Content type: Research article

    Published on:

  35. EMSY could be involved in low-level susceptibility to breast and ovarian cancer. Gene amplification is seen in a proportion of breast and ovarian tumours and correlates with poor prognosis in breast cancer patie...

    Authors: Patrick R Benusiglio, Fabienne Lesueur, Craig Luccarini, Joan McIntosh, Robert N Luben, Paula Smith, Alison Dunning, Douglas F Easton, Bruce AJ Ponder and Paul D Pharoah

    Citation: BMC Cancer 2005 5:81

    Content type: Research article

    Published on:

  36. Recovery of iodide uptake in thyroid cancer cells by means of obtaining the functional expression of the sodium/iodide symporter (NIS) represents an innovative strategy for the treatment of poorly differentiat...

    Authors: Ivan Presta, Franco Arturi, Elisabetta Ferretti, Tiziana Mattei, Daniela Scarpelli, Emanuele Tosi, Angela Scipioni, Marilena Celano, Alberto Gulino, Sebastiano Filetti and Diego Russo

    Citation: BMC Cancer 2005 5:80

    Content type: Research article

    Published on:

  37. Brachytherapy, interstitial tumor bed irradiation, following conservative surgery has been shown to provide excellent local control and limb preservation in patients with soft tissue sarcomas (STS), whereas li...

    Authors: Tadahiko Kubo, Takashi Sugita, Shoji Shimose, Toshihiro Matsuo, Ken Hirao, Hiroaki Kimura, Masahiro Kenjo and Mitsuo Ochi

    Citation: BMC Cancer 2005 5:79

    Content type: Research article

    Published on:

  38. Tumor resistance to chemotherapy may be present at the beginning of treatment, develop during treatment, or become apparent on re-treatment of the patient. The mechanisms involved are usually inferred from exp...

    Authors: Federica Di Nicolantonio, Stuart J Mercer, Louise A Knight, Francis G Gabriel, Pauline A Whitehouse, Sanjay Sharma, Augusta Fernando, Sharon Glaysher, Silvana Di Palma, Penny Johnson, Shaw S Somers, Simon Toh, Bernie Higgins, Alan Lamont, Tim Gulliford, Jeremy Hurren…

    Citation: BMC Cancer 2005 5:78

    Content type: Research article

    Published on:

  39. Chromosomal Comparative Genomic Hybridization (CGH) has been applied to all stages of cervical carcinoma progression, defining a specific pattern of chromosomal imbalances in this tumor. However, given its lim...

    Authors: Alfredo Hidalgo, Michael Baudis, Iver Petersen, Hugo Arreola, Patricia Piña, Guelaguetza Vázquez-Ortiz, Dulce Hernández, José González, Minerva Lazos, Ricardo López, Carlos Pérez, José García, Karla Vázquez, Brenda Alatorre and Mauricio Salcedo

    Citation: BMC Cancer 2005 5:77

    Content type: Research article

    Published on:

  40. By modulating the expression levels of specific signal transduction molecules, the 26S proteasome plays a central role in determining cell cycle progression or arrest and cell survival or death in response to ...

    Authors: Frank Pajonk, Arndt van Ophoven, Christian Weissenberger and William H McBride

    Citation: BMC Cancer 2005 5:76

    Content type: Research article

    Published on:

  41. Cancer prevention trials using different types of antioxidant supplements have been carried out at several occasions and one of the investigated compounds has been the antioxidant N-acetyl-L-cysteine (NAC). St...

    Authors: Anna C Gustafsson, Ilya Kupershmidt, Esther Edlundh-Rose, Giulia Greco, Annalucia Serafino, Eva K Krasnowska, Thomas Lundeberg, Luisa Bracci-Laudiero, Maria-Concetta Romano, Tiziana Parasassi and Joakim Lundeberg

    Citation: BMC Cancer 2005 5:75

    Content type: Research article

    Published on:

  42. Because of the high resistance rate of fibrosarcomas against cytotoxic agents clinical chemotherapy of these tumors is not established. A better understanding of the diverse modes of tumor cell death following...

    Authors: Marcus Lehnhardt, Ludger Klein-Hitpass, Cornelius Kuhnen, Heinz Herbert Homann, Adrien Daigeler, Hans Ulrich Steinau, Sonja Roehrs, Laura Schnoor, Lars Steinstraesser and Oliver Mueller

    Citation: BMC Cancer 2005 5:74

    Content type: Research article

    Published on:

  43. Medical oncologists continue to use performance status as a proxy for quality of life (QOL) measures, as completion of QOL instruments is perceived as time consuming, may measure aspects of QOL not affected by...

    Authors: Sandro J Martins, Nelson Ho, Sueli O Cavamura, Cecilia M Harada, Crystina A Yamamoto and Teresa Y Takagaki

    Citation: BMC Cancer 2005 5:72

    Content type: Research article

    Published on:

  44. Combined chemoradiotherapy (CRT) is the treatment of choice for stage III NSCLC. Gemcitabine (G) is a novel deoxycitidine analogue that has been proven to be a potent radiosensitizer. Twenty-two consecutive pa...

    Authors: Ufuk Abacioglu, Perran F Yumuk, Hale Caglar, Meric Sengoz and Nazim S Turhal

    Citation: BMC Cancer 2005 5:71

    Content type: Research article

    Published on:

Featured videos

View featured videos from across the BMC-series journals